Conversely, patients who achieve target weight loss at 1015 units, or those with marginal tolerability, may not need higher doses
[DOI] [PubMed] [Google Scholar] 85.Robinson B.L., Dumas M., Cuevas E., Gu Q., Paule M.G., Ali S.F., Kanungo J
R&D difficulties and optimization strategies of GLP-1 RAs The short half-life of natural GLP-1 poses a challenge for drug development
What to expect during/after the procedure
This process, triggered by lipid peroxidation and excessive reactive oxygen species (ROS) accumulation, offers a novel perspective on the pathophysiology and potential therapeutic approaches for CHD (5, 6)
individual response, comorbidities, and side-effect profiles determine the appropriate path